Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Sales (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Return on Sales for 16 consecutive years, with 3.42% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 236.0% to 3.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.46% through Dec 2025, down 18.0% year-over-year, with the annual reading at 0.46% for FY2025, 18.0% down from the prior year.
  • Return on Sales hit 3.42% in Q4 2025 for Ironwood Pharmaceuticals, down from 0.33% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 3.76% in Q2 2021 to a low of 10.15% in Q2 2023.
  • Historically, Return on Sales has averaged 0.35% across 5 years, with a median of 0.3% in 2025.
  • Biggest five-year swings in Return on Sales: crashed -1053bps in 2023 and later soared 1014bps in 2024.
  • Year by year, Return on Sales stood at 0.35% in 2021, then soared by 203bps to 1.07% in 2022, then plummeted by -101bps to 0.01% in 2023, then plummeted by -7121bps to 1.07% in 2024, then tumbled by -220bps to 3.42% in 2025.
  • Business Quant data shows Return on Sales for IRWD at 3.42% in Q4 2025, 0.33% in Q3 2025, and 0.28% in Q2 2025.